Status:
COMPLETED
Tricaprilin In Age-Associated Memory Impairment
Lead Sponsor:
Cerecin
Conditions:
Age-Associated Memory Impairment
Eligibility:
All Genders
50-85 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether tricaprilin, a compound that increases energy availability in the brain, improves memory in older adults with "normal" loss of memory abilities since ...
Detailed Description
One physiological hallmark of aging in mammals is a decreased uptake and metabolism of glucose within the brain. The impaired glucose metabolism in the brain may contribute or exacerbate the cognitive...
Eligibility Criteria
Inclusion
- Complaints that memory has declined since young adult life
- Scores on standardized tests that are at least one standard deviation below the mean score of young adults
Exclusion
- Dementia, including Alzheimer's disease and Mild Cognitive Impairment (MCI)
- Drugs that impair cognition
- Psychiatric conditions that may impair cognition (e.g.,depression etc.)
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT00355550
Start Date
July 1 2006
End Date
June 1 2007
Last Update
September 18 2020
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Meridien Research
Brooksville, Florida, United States, 34613
2
University Clinical Research-DeLand
DeLand, Florida, United States, 32720
3
Anchor Research Center
Naples, Florida, United States, 34102
4
Renstar Medical Research
Ocala, Florida, United States, 34471